electroCore (NASDAQ:ECOR) Raised to Strong-Buy at Brookline Cap M

electroCore (NASDAQ:ECOR) was upgraded by Brookline Cap M to a “strong-buy” rating in a report issued on Tuesday,Zacks.com reports. Brookline Cap M also issued estimates for electroCore’s Q4 2025 earnings at ($0.39) EPS, FY2025 earnings at ($1.70) EPS, Q1 2026 earnings at ($0.33) EPS, Q2 2026 earnings at ($0.12) EPS, Q3 2026 earnings at ($0.08) EPS, Q4 2026 earnings at ($0.01) EPS and FY2026 earnings at ($0.53) EPS.

Several other analysts have also recently commented on the stock. Brookline Capital Acquisition raised shares of electroCore to a “strong-buy” rating in a research note on Tuesday. Zacks Research downgraded electroCore from a “hold” rating to a “strong sell” rating in a research report on Wednesday, January 28th. Wall Street Zen upgraded electroCore from a “sell” rating to a “hold” rating in a research report on Saturday, November 8th. HC Wainwright decreased their price target on electroCore from $25.00 to $18.00 and set a “buy” rating on the stock in a research note on Monday, January 26th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of electroCore in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, electroCore has an average rating of “Moderate Buy” and an average target price of $22.00.

electroCore Stock Performance

ECOR stock traded up $0.38 during trading on Tuesday, hitting $5.45. The stock had a trading volume of 25,990 shares, compared to its average volume of 85,068. The stock has a market cap of $43.60 million, a price-to-earnings ratio of -3.19 and a beta of 0.48. The company’s 50 day moving average price is $5.58 and its two-hundred day moving average price is $5.44. electroCore has a 1-year low of $4.16 and a 1-year high of $19.49.

electroCore (NASDAQ:ECOR) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.40) EPS for the quarter, missing analysts’ consensus estimates of ($0.33) by ($0.07). The firm had revenue of $8.69 million for the quarter, compared to analysts’ expectations of $7.84 million. electroCore had a negative return on equity of 447.87% and a negative net margin of 47.46%. As a group, sell-side analysts forecast that electroCore will post -1.49 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of ECOR. FNY Investment Advisers LLC acquired a new stake in shares of electroCore in the fourth quarter valued at about $82,000. Two Sigma Investments LP grew its position in electroCore by 20.8% in the third quarter. Two Sigma Investments LP now owns 24,603 shares of the company’s stock valued at $122,000 after acquiring an additional 4,231 shares in the last quarter. Cubist Systematic Strategies LLC purchased a new stake in shares of electroCore during the first quarter valued at approximately $153,000. Jaffetilchin Investment Partners LLC lifted its position in shares of electroCore by 26.7% during the second quarter. Jaffetilchin Investment Partners LLC now owns 41,783 shares of the company’s stock worth $221,000 after purchasing an additional 8,800 shares in the last quarter. Finally, Jane Street Group LLC lifted its position in shares of electroCore by 114.4% during the first quarter. Jane Street Group LLC now owns 36,726 shares of the company’s stock worth $246,000 after purchasing an additional 19,599 shares in the last quarter. Hedge funds and other institutional investors own 26.74% of the company’s stock.

Key Stories Impacting electroCore

Here are the key news stories impacting electroCore this week:

• Positive Sentiment: Brookline Capital Management upgraded ECOR to a “Strong-Buy” and published new estimates that point toward improving profitability — forecasting FY2026 EPS of ($0.53) and a near-breakeven Q4 2026 EPS of ($0.01), which investors may view as a catalyst for the stock. Zacks Upgrade
• Neutral Sentiment: Brookline released a detailed quarter-by-quarter EPS schedule (Q4 2025: ($0.39); Q1 2026: ($0.33); Q2 2026: ($0.12); Q3 2026: ($0.08); Q4 2026: ($0.01)) giving investors a roadmap for when improvement is expected, but these are analyst projections rather than company guidance. MarketBeat Estimates
• Negative Sentiment: Despite the upgrade, Brookline still models a sizable loss for FY2025 (forecast: ($1.70) EPS), which is worse than the current consensus full-year estimate of ($1.49) — a reminder that near-term profitability and cash flow remain risk factors. MarketBeat Estimates

About electroCore

electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.

The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.